Following the American Society of Neuroradiology (ASNR) meeting, MedPage Today convened three leaders in neuro-oncology and brain tumor imaging for a virtual roundtable discussion on the evolving role of advanced MRI in brain tumor care. Moderator Suyash Mohan, MD, of the University of Pennsylvania in Philadelphia, is joined by Caroline Chung, MD, of the University of Texas MD Anderson Cancer Center in Houston, and Steven Brem, MD, also of the University of Pennsylvania.
In this first of four episodes, the panel discusses where advanced neuroimaging is already influencing patient care, from surgical planning and treatment navigation to radiation therapy decision-making. The conversation also explores how clinicians are moving beyond purely anatomic imaging toward quantitative and biologic markers that may help personalize care for patients with brain tumors.
Following is a transcript of their remarks:
Mohan: Hello, everyone and welcome. My name is Suyash Mohan. I'm a neuroradiologist at the University of Pennsylvania where I direct the neuroradiology clinical research division and I also co-direct our annual brain tumor CME.
I'm delighted to moderate the session on modern neuroimaging and the evolving role it plays in brain tumor care. We are going to focus on what changes management today, where advanced MRI truly adds value, where standardization and overuse are problematic, and what should we realistically expect from biomarkers and artificial intelligence over the next few years. Put differently, less of a crystal ball but more of practical points.
